Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearh... NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.25 | -50 | 0.5 | 0.5595 | 0.1 | 2292617 | 0.23517236 | CS |
| 4 | -0.2146 | -46.190271201 | 0.4646 | 0.91 | 0.1 | 11776264 | 0.65204359 | CS |
| 12 | -0.2505 | -50.04995005 | 0.5005 | 0.9649 | 0.1 | 4342037 | 0.65020153 | CS |
| 26 | -0.54 | -68.3544303797 | 0.79 | 0.9649 | 0.1 | 2646874 | 0.604772 | CS |
| 52 | -1.76 | -87.5621890547 | 2.01 | 3.1 | 0.1 | 2136603 | 1.01657494 | CS |
| 156 | -5.73 | -95.8193979933 | 5.98 | 6.7 | 0.1 | 1830705 | 1.19628033 | CS |
| 260 | -5.73 | -95.8193979933 | 5.98 | 6.7 | 0.1 | 1830705 | 1.19628033 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
